comp360
Generic: psilocybin·Code: COMP360
comp360: developed by 1 company · 1 FDA decision. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| COMPASS Pathways plc (CMPS) | Phase 3 |
FDA Decisions
FDA_MeetingCompany submitted a request for a meeting with the FDA to discuss a rolling submission and review for COMP360 psilocybin treatment.(CMPS)
Frequently asked questions
Who is developing comp360?
comp360 is being developed by COMPASS Pathways plc.
What is comp360's latest FDA decision?
The most recent tracked FDA decision for comp360 is FDA_Meeting for Company submitted a request for a meeting with the FDA to discuss a rolling submission and review for COMP360 psilocybin treatment..
Get deeper analysis on comp360
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis